An exocrine pancreatic function test using secretin-cholecystokinin or caerulein is considered the best test possible because of its high sensitivity and specificity. 1, 2) However, this test is complex, time consuming, unpleasant for the patient and not feasible in some cases. Therefore, many alternative methods have been developed, such as the p-aminobenzoic acid and fluorescein dilaurate tests, serum trypsin and faecal chymotrypsin concentrations, 3) and enzyme linked immunosorbent assay for elastase in feces. 4) The ideal exocrine pancreatic function test, however, would be sensitive, specific, easy to perform, non-invasive and inexpensive.
On the other hand, 13 C-breath tests have been developed as a nonradioactive alternative method. Ghoos and colleagues 5) developed a breath test in 1993 to monitor gastric emptying using 13 C-labelled acetic acid. In 2007, Kohno and colleagues 6) synthesized 13 
C-dipeptide, N-benzoyl-L-tyrosyl-1-13 C-L-alanine sodium, and evaluated pancreatic exocrine function by administering N-benzoyl-L-tyrosyl-1-

13
C-L-alanine sodium dissolved in distilled water to anesthetized or conscious rats. However, it is important to perform a breath test non-invasively while the animal is in a conscious and physiologically functioning state. Nutrients in the test meal also affect the pancreatic exocrine function. Recently, we developed a simple breath test system for monitoring gastric emptying non-invasively using Racol (an enteral nutritional formula) containing 13 C-labeled acetic acid in conscious rats. 6) Racol has been used in clinics to investigate the gastric emptying. This study thus aimed to evaluate the pancreatic exocrine function using Racol containing N-benzoyl-L-tyrosyl-1-13 C-L-alanine sodium and a recently developed simple and non-invasive breath test system.
On the other hand, pancreatic exocrine function is known to be low in patients of pancreatitis. However, the effect of diabetes on the pancreatic exocrine function has not been clarified particularly in experimental animals. To evaluate the usefulness of the present method, this function was thus investigated in the alloxan-induced diabetic rats.
In diabetic patients, the gastric emptying rate is known to be delayed. To determine the effect of pancreatic insufficiency resulting from diabetic mellitus due to the slower gastric emptying rate, we further tested the effect of this condition on the change of expired air from 1-13 C-L-alanine which is digested by pancreatic enzymes from N-benzoyl-L-tyrosyl-1-13 C-L-alanine sodium.
MATERIALS AND METHODS
The following animal studies were performed according to "Guiding Principles for the Care and Use of Laboratory Animals" approved by The Japanese Pharmacological Society.
Animals Male Fisher-344 rats (200-250 g) were purchased from SLC (Shizuoka, Japan), and kept for 1 week before experiments in a room where the temperature and humidity were kept at 21Ϯ2°C and 55Ϯ15%, respectively. The light and dark cycle was 12 h, and light period was from 7:00 to 19:00. Rats were fasted in mesh cages for one night to prevent coprophagy before each experiment, but had free access to drinking water.
Breath Test Using N-Benzoyl-L-tyrosyl-1-ceutical Co., Ltd., Japan). Rats were placed in the chamber just after the oral administration of a sample containing N-benzoyl-L-tyrosyl-1-
13
C-Lalanine sodium or 1-13 C-L-alanine. Expired 13 CO 2 air was collected and measured at 5 min intervals for 70 min, then by at 90 and 120 min after sample administration. Expired 13 CO 2 air was collected for 1.5 min at each sampling time. Ventilation volume was 150 ml/min.
Evaluation of Breath Test
The measured values were presented as the D 13 CO 2 (‰). The maximum concentration (C max ; ‰), the time taken to reach the maximum concentration (T max ; min) and the area under the curve (AUC 120 min ; ‰ · min) were calculated using the D
13
CO 2 values. C max and AUC 120 min reflect the absorption of digested materials by protease.
13 C-L-alanine sodium was dissolved in Racol (enteral nutritional formula) and administered in a volume of 2.5 ml/kg.
C-L-alanine sodium were 10, 30 and 100 mg/kg. Induction of Alloxan-Induced Diabetes Diabetes was induced by the intravenous administration of alloxan dissolved in saline at a dose of 40 mg/kg (2.5 ml/kg) according to the methods reported previously with slight modification. [8] [9] [10] In the control rats, saline was administered instead of alloxan.
Blood glucose levels were measured with a Glucometer DEX (Bayer Health Care, U.S.A.) on Day 2 after alloxan administration.
Effect of Alloxan-Induced Diabetes on the Expired 13 CO 2 Air from N-Benzoyl-L-tyrosyl-1-
C-L-alanine Sodium Two days after alloxan administration, rats were fasted for one night, and a breath test was performed by the method described above. In brief, 30 mg/kg of N-benzoyl-Ltyrosyl-1-13 C-L-alanine sodium dissolved in Racol was administered orally at 2.5 ml/kg and expired 13 CO 2 air was monitored for 120 min. The same treatment was performed in the control rats.
Effect of Alloxan-Induced Diabetes on the Expired 
13 C-L-alanine sodium and Racol were purchased from Tokyo Gas Chemical Co., Ltd. (Tokyo, Japan) and Ohtsuka Pharmaceutical Co., Ltd., respectively. 1-13 C-L-Alanine and alloxan were purchased from Isotec (Miamisburg, Ohio, U.S.A.) and Sigma (Tokyo), respectively.
Statistical Analysis Results were represented as the meanϮS.E.M. of animals used. Statistical analyses were performed by a Student's t-test and values of pϽ0.05 were regarded as significant.
RESULTS
Dose-Dependency of N-Benzoyl-L-tyrosyl-1-
13
C-L-alanine Sodium Expired 13 CO 2 air increased with time after ingestion in a dose-dependent manner, peaked and decreased thereafter (Fig. 1) .
C max values increased in a dose-dependent manner (Table   1) . A significant positive correlation was observed between
C-L-alanine sodium and C max values ( Fig. 2A) (pϽ0.05) .
The value of AUC 120 min also increased in a dose-dependent manner (Table 1) . A significant positive correlation was observed between doses of N-benzoyl-L-tyrosyl-1-13 C-L-alanine sodium and AUC 120 min values (Fig. 2B) (pϽ0.05) . T max values were delayed as the dosage was increased ( Table 1) .
C-L-alanine Sodium On Day 2 after diabetes induction, blood glucose levels were 126Ϯ6.0 and 415Ϯ11.1 mg/dl in the control group and diabetes-induced group, respectively. A significant difference was observed between the two groups (pϽ0.01). The effect of alloxan-induced diabetes is shown in Fig. 3 . In the control rats, expired 13 CO 2 air increased with time after ingestion, peaked at 22.5 min and decreased thereafter. In the diabetic rats, expired 13 CO 2 air changed at lower levels and significant differences were observed at 5, 10 and 45 min after administration as compared with the control rats.
C max value in diabetic rats showed a tendency to decrease (pϽ0.10). T max value also showed a tendency to be delayed (pϽ0.10) ( Table 2 ). However, AUC 120 min values were not significantly different between the two groups.
Effect of Alloxan-Induced Diabetes on the Expired 13 CO 2 Air from 1-
C-L-Alanine On Day 2 after diabetes induction, blood glucose levels were 129Ϯ4.2 and 428Ϯ 3.6 mg/dl in the control group and diabetes-induced group, respectively. A significant difference was observed between the two groups (pϽ0.01).
The effect of alloxan-induced diabetes on the expired 13 CO 2 air form 1-13 C-L-alanine sodium is shown in Fig. 4 . In the control rats, this expired air increased, peaked and decreased over time. In the diabetic rats, this expired 13 CO 2 air changed at markedly lower levels as compared with control rats, although significant differences were not observed between the two groups.
C max and AUC 120 min values in diabetic rats are shown in Table 3 and are not significantly different from those in the control rats. However, T max value in diabetic rats showed a tendency to be delayed (pϽ0.10).
DISCUSSION
It is assumed that orally administered N-benzoyl-L-tyrosyl-
C-L-alanine sodium is evacuated to the duodenum, where it is cleaved by one of the pancreatic proteases, carboxypeptidase, thereby releasing 13 C-alanine. 13 C-Alanine is then rapidly absorbed from the intestinal mucosa and metabolized in the liver. Thereafter, 13 CO 2 air is exhaled from the mouth. Kohno and colleagues 6) evaluated the pancreatic exocrine function in anesthetized or conscious rats after oral administration of N-benzoyl-L-tyrosyl-1-13 C-L-alanine sodium. However, it is important to perform breath test non-invasively while the rat is in a physiological state. Therefore, we used our recently developed breath test system using conscious rats. 7) In the present study, exhaled C-L-alanine sodium is digested by the protease secreted from the pancreas, and that the monitoring of the expired 13 CO 2 air from this reflects the pancreatic exocrine function.
Lembcke and colleagues 11) reported that in patients with pancreatic disease, the 13 C-Hiolein breath test reflects impaired lipase output indicating decompensated lipolysis. The breath test using 13 C-Hiolein is a convenient alternative to faecal fat analysis. Löser and colleagues 12) reported that the 13 C-mixed triglyceride breath test reflects severe exocrine pancreatic insufficiency (steatorrhea) but has limited sensi- Values represents the meanϮS.E. (nϭ4). * shows a tendency to be delayed (pϽ0.10).
tivity for the detection of mild cases. Ishii and colleagues 13) reported that the N-benzoyl-L-tyrosyl-1-
13
C-L-alanine breath test can quickly, safely and non-invasively diagnose exocrine pancreatic dysfunction in a clinical study and found that expired 13 CO 2 values at 10-60 min for this test were significantly lower in chronic pancreatitis patients than in normal controls. In general, pancreatic exocrine function is known to be low in pancreatitis patients.
On the other hand, diabetes mellitus is also known to be associated with pancreatic atrophy and compromised digestion of carbohydrates as a result of exocrine pancreatic insufficiency and lower alpha-amylase synthesis and secretion. Kahara and colleagues 14) reported that the pancreatic exocrine and endocrine events might occur concomitantly but independently during the course of fulminant type 1 diabetes mellitus. To estimate the usefulness of the present method, we evaluated the pancreatic exocrine function in alloxan-induced diabetes rats (type 1 diabetes mellitus) in this study. In the diabetic rats, the exhaled 13 CO 2 air changed at significantly lower levels than in the control rats. This finding is the first breath test report showing that pancreatic exocrine function was insufficient in alloxan-induced diabetic rats. Alvarez and López 15) reported that total protein and amylase secretion decreased markedly in the alloxan-induced diabetic rabbits. This may support our present findings that pancreatic exocrine function was insufficient in alloxan-induced diabetic rats, although the experimental conditions were different from each other. However, C max , T max and AUC 120 min values of diabetic rats were not significantly different from those of the control rats. Although the reason of no difference is not clear, experimental date may be too early. On this point, further investigations would be needed.
A delay in gastric emptying is known in diabetic mellitus. Matsumoto and colleagues 16) reported that insulin dependent diabetes patients showed slower gastric emptying than noninsulin dependent diabetes patients, and the 13 C-octanoic acid breath test is useful for evaluating diabetic mellitus patients with delayed gastric emptying. Then, we tested the changes of expired 13 CO 2 air from 1-13 C-L-alanine in alloxan-induced diabetic rats to classify the effect of pancreatic insufficiency from the delay of gastric emptying rate. In diabetic rats, expired 13 CO 2 air was markedly lower than that of the control rats and T max showed a tendency to be delayed, suggesting the delay of gastric emptying rate. However, the change of expired 13 CO 2 air from N-benzoyl-L-tyrosyl-1-13 C-L-alanine was significantly lower than that of the control rats. This difference may therefore indicate a pancreatic exocrine insufficiency, although a delay in gastric emptying was observed.
In conclusion, pancreatic exocrine function was evaluated using N-benzoyl-L-tyrosyl-1-
C-L-alanine sodium and our recently developed non-invasive breath test system in conscious rats. Moreover, insufficiency of the pancreatic exocrine function was observed in alloxan-induced diabetic rats. These results confirm that this method is useful to evaluate pancreatic exocrine function.
